The Trump administration surprisingly requested a federal judge dismiss a lawsuit limiting access to the abortion pill mifepristone.
This action mirrors the Biden administration's stance, creating a surprising development given Trump's anti-abortion record.
The lawsuit challenges FDA regulations expanding mifepristone access since 2016, significantly impacting abortion availability.
The administration's filing focuses on procedural grounds, avoiding the substantive merits of the controversial case.
